Home > Insider Trading > Filing (0000921895-22-003084)

Filing Details

Accession Number:: 0000921895-22-003084
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-11-17 17:42:39
Reporting Period:: 2022-11-15

Accepted Time:: 2022-11-17 17:42:39
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
707388	Star Equity Holdings Inc.	STRR	Electromedical & Electrotherapeutic Apparatus (3845)	330145723

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1548312	E. Jeffrey Eberwein	C/O Star Equity Holdings, Inc. 53 Forest Avenue, Suite 101 Old Greenwich CT 06870	Executive Chairman	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-11-15	8,631	$0.00	2,757,777	No	4	M	Direct
Common Stock	Acquisiton	2022-11-15	10,000	$0.90	2,767,777	No	4	P	Direct
Common Stock	Acquisiton	2022-11-16	10,000	$0.91	2,777,777	No	4	P	Direct
Common Stock	Acquisiton	2022-11-17	10,000	$0.90	2,787,777	No	4	P	Direct
10% Series A Cumulative Perpetual Preferred Stock	Disposition	2022-11-15	6,447	$9.89	1,233,795	No	4	S	Direct
10% Series A Cumulative Perpetual Preferred Stock	Disposition	2022-11-16	200	$9.89	1,233,595	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Unit	Disposition	2022-11-15	8,631	$0.00	8,631	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	M	Direct

Footnotes

Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock.
This transaction represents the settlement of Restricted Stock Units in shares of common stock on their scheduled vesting date.
The purchases of the shares reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Eberwein.
The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $0.90 to $0.93, rounded to the nearest cent, inclusive. Mr. Eberwein undertakes to provide the Issuer and any security holder of the Issuer, 3or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.
The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $0.88 to $0.95, rounded to the nearest cent, inclusive. Mr. Eberwein undertakes to provide the Issuer and any security holder of the Issuer, 3or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.
The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $0.86 to $0.93, rounded to the nearest cent, inclusive. Mr. Eberwein undertakes to provide the Issuer and any security holder of the Issuer, 3or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.
The sales of the shares reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Eberwein.
On November 15, 2021 the Reporting Person was granted 8,631 Restricted Stock Units. As to this grant, 100% of the Restricted Stock Units fully vested on November 15, 2022.